Log In
Print
BCIQ
Print
Print this Print this
 

ND0612, ND0612L

  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionLevodopa and carbidopa liquid formula administered via subcutaneous delivery patch pump device
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat moderate Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today